3 completed. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Completed 3 |
Follow Chronic Kidney Failure: new trials by email Literature Review of Chronic Kidney Failure trials Research Report on Chronic Kidney Failure
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy of Sodium Polystyrene Sulfonate in the Treatment of Hyperkaliemia in Pre-dialysis Patients Sodium polystyrene sulfonate, Lactose with carob gum - Hyperkalemia, Chronic Kidney Failure | Phase 4 | Completed | Maisonneuve-Rosemont Hospital | 38 | 2014-02-01 | 2014-10-03 |
| 13 Valent Pneumococcal Conjugate Vaccine in Chronic Dialysis Patients PPV23 vaccination or PCV13 vaccination - Chronic Kidney Failure | Phase 4 | Completed | AZ Sint-Jan AV | 154 | 2013-02-01 | 2015-07-08 |
| Study Evaluating Sirolimus in End Stage Renal Disease in High Risk Kidney Transplant Recipients Rapamune - Chronic Kidney Failure, Graft vs Host Disease | Phase 4 | Completed | Wyeth is now a wholly owned subsidiary of Pfizer | 484 | 2009-08-18 |
Kidney Failure, Chronic (3) · Graft vs Host Disease (1) · Hyperkalemia (1)
Chronic Disease (3) · Disease Attributes (3) · Female Urogenital Diseases (3) · Female Urogenital Diseases and Pregnancy Complications (3) · Kidney Diseases (3) · Male Urogenital Diseases (3) · Pathologic Processes (3) · Pathological Conditions, Signs and Symptoms (3) · Renal Insufficiency (3) · Renal Insufficiency, Chronic (3) · Urogenital Diseases (3) · Urologic Diseases (3) · Immune System Diseases (1) · Metabolic Diseases (1) · Nutritional and Metabolic Diseases (1)
13-valent pneumococcal vaccine (1) · Lactose (1) · Sirolimus (1) · polystyrene sulfonic acid (1)
AZ Sint-Jan AV (1) · Maisonneuve-Rosemont Hospital (1) · Wyeth is now a wholly owned subsidiary of Pfizer (1)
Belgium (1) · Canada (1)
Stefaan J Vandecasteele, MD, PhD (1) · Vincent Pichette, MD (1)